Rajeev Shah

Ra Capital Management, L.p.

Assets Managed

$9.438B

Holdings

Last Quarter

2026 - Q1

Filed Date

1mo 5d ago

Growth Rate

-3.31%(2Q avg: 8.49%)

Sustained Growth

0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ra Capital Management, L.p.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 85 positions.

Assets under management

The assets under management (AUM) of Ra Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 9.438B in assets, with a quarterly growth rate of -3.31% and a 2-quarter average growth rate of 8.49%. The portfolio is managed by Rajeev Shah, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
ASND Ascendis Pharma A S - Adr Recent Activity	24.92%	$2.352B 10.281M shares@ $228.73 avg price
PCVX Vaxcyte Inc Recent Activity Increased 7%	7.07%	$666.789M 11.475M shares@ $58.12 avg price	Increased 7%
RYTM Rhythm Pharmaceuticals Inc Recent Activity	6.15%	$579.815M 6.667M shares@ $86.98 avg price
TYRA Tyra Biosciences Inc Recent Activity	4.96%	$467.207M 12.199M shares@ $38.31 avg price
SION Sionna Therapeutics Inc Recent Activity	4.21%	$397.093M 9.905M shares@ $40.09 avg price
EWTX Edgewise Therapeutics Inc Recent Activity	3.49%	$328.496M 10.428M shares@ $31.51 avg price
NAMS Newamsterdam Pharma Co Nv Recent Activity	3.24%	$305.702M 9.55M shares@ $32.02 avg price
NUVL Nuvalent Inc-a Recent Activity Increased 34.8%	2.76%	$259.623M 2.534M shares@ $102.45 avg price	Increased 34.8%
DNTH Dianthus Therapeutics Inc Recent Activity Increased 62.05%	2.33%	$219.177M 2.612M shares@ $83.92 avg price	Increased 62.05%
MLYS Mineralys Therapeutics Inc Recent Activity Increased 5.04%	2.21%	$208.397M 7.693M shares@ $27.1 avg price	Increased 5.04%

1-10 of 85